Related Experiment Videos
Epidemiology, pathogenesis and therapeutic modalities in hemolytic-uremic syndrome
1Universitäts-Kinderklinik, Freiburg, Deutschland. hackl@kkl200.ukl.uni-freiburg.de
Kidney & Blood Pressure Research
|October 8, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
The New England journal of medicine·2013
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
Clinical journal of the American Society of Nephrology : CJASN·2012
Lyme neuroborreliosis: aetiology and diagnosis of facial palsy in children from Tyrol.
Klinische Padiatrie·2010
Successful treatment of severe juvenile microscopic polyangiitis with rituximab.
Clinical rheumatology·2009
Successful implantation of a cochlear implant in a four-yr-old boy after kidney transplantation: a case report.
Pediatric transplantation·2008
Impact of Renal Replacement Therapy on Severe Lactic Acidosis in ICU Patients: A MIMIC-IV retrospective replication analysis.
Kidney & blood pressure research·2026
Peritoneal dialysis-associated peritonitis in two patients with Bartter syndrome and end-stage kidney disease: a case report.
Kidney & blood pressure research·2026
Nutritional Status as Predictor for Mortality in Older Adults With Acute Kidney Injury.
Kidney & blood pressure research·2026
Nephrogenic Diabetes Insipidus Presenting with Hypokalemic Paralysis in an Adolescent with Primary Sjögren's Syndrome: A Case Report.
Kidney & blood pressure research·2026
Endothelial-to-Mesenchymal Transition in Chronic Kidney Disease: Mechanisms and Therapeutic Targets.
Kidney & blood pressure research·2026
Prognostic value of claims data for chronic kidney disease associated health risks.
Kidney & blood pressure research·2026
Clonal hematopoiesis in immune-related and neurological disorders.
Immunological medicine·2026
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
British journal of haematology·2026
Recurrent Postpartum Atypical Hemolytic Uremic Syndrome Caused by a C3 Pathogenic Variant: A Case Report.
International journal of women's health·2026